Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Centessa Pharmaceuticals

Biotech & Life Sciences · Boston, United States · Founded 2021 · IPO 2021 Unicorn

Merger of ten pharmaceutical companies developing drugs for sleep-wake disorders, neurological conditions and cancer

Valuation
$5.92B
Market cap · May/2026
Revenue
$15M
Latest reported FY

Investors

14 investors on Centessa Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 14 investors entered at this stage

Global footprint

Where Centessa Pharmaceuticals has talent and traffic

Workforce by country
5 countries with
team presence
🇺🇸 United States88.3%
🇬🇧 United Kingdom9.3%
🇫🇷 France1.3%
🇨🇭 Switzerland1.2%
🇮🇪 Ireland1.1%
5 countries shown
Web traffic by country
21K monthly visits
across markets
🇺🇸 United States81%
🇬🇧 United Kingdom10%
🇮🇳 India4.8%
🇧🇪 Belgium2.4%
Top 4 markets shown

Patent intelligence

$34M patent portfolio · 12 active families

Estimated portfolio value
$34M
0.57% of market cap · comparable to top peer Advanced Accelerator Applications ($23M)
12 active patent families
Where Centessa Pharmaceuticals innovates PeptideAntigen processingMolecular biologyT cellAntigen Processing Cell

Where Centessa Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Centessa Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Centessa Pharmaceuticals's 10 investments and acquisitions.

Every disclosed deal where Centessa Pharmaceuticals appeared as a backer or acquirer, 2021–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

10 deals across Centessa Pharmaceuticals's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Centessa Pharmaceuticals deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Centessa Pharmaceuticals's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        10 of 10 deals

        Market sentiment

        What the market is saying about Centessa Pharmaceuticals

        An AI-synthesized read of the highest-engagement posts about Centessa Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Centessa Pharmaceuticals on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.